Innovation Pharmaceuticals Inc (IPIX)

[DrBones]

EUA granted for VIR after two months. Trial was originally halted due to concerns of lack of benefit. Trial still currently recruiting. (https://clinicaltrials.gov/ct2/show/NCT04779879?term=VIR-7831&draw=2&rank=1)

Will IPIX have the efficacy to take such a course, my bet says yes. Being Small Pharma it will have to be stellar though.

“Glaxo and Vir also reported positive results in March for low-risk patients from a study combining their antibody treatment with a drug from Eli Lilly & Co. The cocktail of VIR-7831 with Lilly’s bamlanivimab reduced the amount of virus present in patients with mild-to-moderate Covid infection by 70% after seven days.

All three companies have suffered setbacks with their antibody studies.

Authorization for Lilly’s drug on its own was revoked in April as concerns arose of reduced effectiveness against Covid variants; bamlanivimab is now cleared for use only in tandem with another Lilly antibody.

Glaxo and Vir halted a late-stage study in March looking at the effects of VIR-7831 in already hospitalized patients after an independent monitoring board raised concerns about the extent of the potential benefit.”


https://www.bloomberg.com/news/articles/2021-05-26/glaxo-vir-granted-u-s-clearance-for-covid-19-antibody-drug